What’s at stake: The country’s largest independent science centre claims it is struggling to get funding for research into a potentially billion-dollar opportunity.
Background: Cawthron Institute has created the world’s first algae-based pain medication, which would be opioid-free.
Key players: Cawthron Institute, Volker Kuntzsch, Cath McLeod.
New Zealand’s largest independent science centre, Cawthron Institute, is struggling to get funding for research into an algae-based local anaesthetic which it says has billion-dollar potential.
Cawthron Institute chief executive Volker Kuntzsch said it had yet to find the funding required to
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
What’s at stake: The country’s largest independent science centre claims it is struggling to get funding for research into a potentially billion-dollar opportunity.
Background: Cawthron Institute has created the world’s first algae-based pain medication, which would be opioid-free.
Key players: Cawthron Institute, Volker Kuntzsch, Cath McLeod.
